Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse-Remitting Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07235644
What this trial is testing

Comparison of Efficacy and Safety in Patients Switching From MabThera® to Rixathon® in Relapsing-Remitting Multiple Sclerosis

Who this might be right for
MS (Multiple Sclerosis)Multiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (Relapsing Remitting)
Uppsala University 184
Large-scale testing (Phase 3)Study completedNCT02290444
What this trial is testing

Effects of Acthar on Recovery From Cognitive Relapses in MS

Who this might be right for
Multiple Sclerosis
State University of New York at Buffalo 64
Testing effectiveness (Phase 2)Ended earlyNCT02306811
What this trial is testing

Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Genzyme, a Sanofi Company 62
Large-scale testing (Phase 3)Ended earlyNCT01797965
What this trial is testing

Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019

Who this might be right for
Relapsing-Remitting Multiple SclerosisMultiple Sclerosis
Biogen 1,501
Not applicableUnknownNCT03610139
What this trial is testing

Longitudinal Effect of Vitamin D3 Replacement on Cognitive Performance and MRI Markers in Multiple Sclerosis Patients

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingClinically Isolated Syndrome+2 more
American University of Beirut Medical Center 162
Testing effectiveness (Phase 2)Study completedNCT02424396
What this trial is testing

Biological Activity and Safety of Low Dose IL2 in Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris 30
Testing effectiveness (Phase 2)Ended earlyNCT03387046
What this trial is testing

A Pilot Study in Participants With Relapsing Remitting Multiple Sclerosis (RR-MS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 7
Post-approval studies (Phase 4)Ended earlyNCT03126760
What this trial is testing

Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Mallinckrodt ARD LLC 35
Large-scale testing (Phase 3)Looking for participantsNCT07321093
What this trial is testing

The Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis (RRMS)
Biocad 292
Large-scale testing (Phase 3)Active Not RecruitingNCT04688788
What this trial is testing

Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple SclerosisSecondary Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis
Rigshospitalet, Denmark 600
Post-approval studies (Phase 4)Study completedNCT01333501
What this trial is testing

Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 151
Large-scale testing (Phase 3)Study completedNCT00027300
What this trial is testing

Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 900
Not applicableEnded earlyNCT05978531
What this trial is testing

Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Banner Life Sciences LLC 25
Not applicableLooking for participantsNCT07355387
What this trial is testing

Home Based Functional Balance Intervention for Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+2 more
University of Illinois at Chicago 75
Testing effectiveness (Phase 2)Study completedNCT01071083
What this trial is testing

Treatment Interruption of Natalizumab

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen 175
Testing effectiveness (Phase 2)Study completedNCT02087631
What this trial is testing

Safety and Tolerability of Quetiapine in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of Calgary 14
Post-approval studies (Phase 4)UnknownNCT05902429
What this trial is testing

Effects of Oral Cladribine on Remyelination and Inflammation in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Pontificia Universidade Católica do Rio Grande do Sul 10
Not applicableNot Yet RecruitingNCT04768777
What this trial is testing

Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingSexual Dysfunction
University of Alabama at Birmingham 30
Not applicableStudy completedNCT03691766
What this trial is testing

Photobiomodulation Therapy in Persons With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Marquette University 21
Not applicableLooking for participantsNCT05964829
What this trial is testing

Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic Progressive
Cionic, Inc. 14
Next Page